These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 12618764)

  • 1. MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion.
    Mehta PB; Jenkins BL; McCarthy L; Thilak L; Robson CN; Neal DE; Leung HY
    Oncogene; 2003 Mar; 22(9):1381-9. PubMed ID: 12618764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitogenic growth signalling, DNA replication licensing, and survival are linked in prostate cancer.
    Dudderidge TJ; McCracken SR; Loddo M; Fanshawe TR; Kelly JD; Neal DE; Leung HY; Williams GH; Stoeber K
    Br J Cancer; 2007 May; 96(9):1384-93. PubMed ID: 17406359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ERK5 signalling in prostate cancer promotes an invasive phenotype.
    Ramsay AK; McCracken SR; Soofi M; Fleming J; Yu AX; Ahmad I; Morland R; Machesky L; Nixon C; Edwards DR; Nuttall RK; Seywright M; Marquez R; Keller E; Leung HY
    Br J Cancer; 2011 Feb; 104(4):664-72. PubMed ID: 21266977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADAM17 targets MMP-2 and MMP-9 via EGFR-MEK-ERK pathway activation to promote prostate cancer cell invasion.
    Xiao LJ; Lin P; Lin F; Liu X; Qin W; Zou HF; Guo L; Liu W; Wang SJ; Yu XG
    Int J Oncol; 2012 May; 40(5):1714-24. PubMed ID: 22200661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B viral HBx induces matrix metalloproteinase-9 gene expression through activation of ERK and PI-3K/AKT pathways: involvement of invasive potential.
    Chung TW; Lee YC; Kim CH
    FASEB J; 2004 Jul; 18(10):1123-5. PubMed ID: 15132991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MAPKAPK2 and HSP27 are downstream effectors of p38 MAP kinase-mediated matrix metalloproteinase type 2 activation and cell invasion in human prostate cancer.
    Xu L; Chen S; Bergan RC
    Oncogene; 2006 May; 25(21):2987-98. PubMed ID: 16407830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of E6-associated protein on the proliferation and invasion of prostate cancer cells in bone metastasis.
    Zhang L; Hu X; Chen J; Fu G
    Int J Clin Exp Pathol; 2015; 8(6):6571-5. PubMed ID: 26261538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor effects of the novel quinazolinone MJ-33: inhibition of metastasis through the MAPK, AKT, NF-κB and AP-1 signaling pathways in DU145 human prostate cancer cells.
    Hour MJ; Tsai SC; Wu HC; Lin MW; Chung JG; Wu JB; Chiang JH; Tsuzuki M; Yang JS
    Int J Oncol; 2012 Oct; 41(4):1513-9. PubMed ID: 22825655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-Jun NH2-terminal kinase pathway is involved in constitutive matrix metalloproteinase-1 expression in a hepatocellular carcinoma-derived cell line.
    Sugioka Y; Watanabe T; Inagaki Y; Kushida M; Niioka M; Endo H; Higashiyama R; Okazaki I
    Int J Cancer; 2004 May; 109(6):867-74. PubMed ID: 15027120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant expression of extracellular signal-regulated kinase 5 in human prostate cancer.
    McCracken SR; Ramsay A; Heer R; Mathers ME; Jenkins BL; Edwards J; Robson CN; Marquez R; Cohen P; Leung HY
    Oncogene; 2008 May; 27(21):2978-88. PubMed ID: 18071319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PBK/TOPK enhances aggressive phenotype in prostate cancer via β-catenin-TCF/LEF-mediated matrix metalloproteinases production and invasion.
    Brown-Clay JD; Shenoy DN; Timofeeva O; Kallakury BV; Nandi AK; Banerjee PP
    Oncotarget; 2015 Jun; 6(17):15594-609. PubMed ID: 25909225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type IV collagenase (matrix metalloproteinase-2 and -9) in prostate cancer.
    Zhang L; Shi J; Feng J; Klocker H; Lee C; Zhang J
    Prostate Cancer Prostatic Dis; 2004; 7(4):327-32. PubMed ID: 15356679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of MEK5 by Stat3 promotes breast cancer cell invasion and metastasis.
    Liu F; Zhang H; Song H
    Oncol Rep; 2017 Jan; 37(1):83-90. PubMed ID: 27878304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of MMP-9 in ERK-mutated stable transfectants inhibits glioma invasion in vitro.
    Lakka SS; Jasti SL; Gondi C; Boyd D; Chandrasekar N; Dinh DH; Olivero WC; Gujrati M; Rao JS
    Oncogene; 2002 Aug; 21(36):5601-8. PubMed ID: 12165859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidermal growth factor receptor signaling and the invasive phenotype of ovarian carcinoma cells.
    Alper O ; Bergmann-Leitner ES; Bennett TA; Hacker NF; Stromberg K; Stetler-Stevenson WG
    J Natl Cancer Inst; 2001 Sep; 93(18):1375-84. PubMed ID: 11562388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of matrix metalloproteinases mediates thromboxane A2-induced invasion in lung cancer cells.
    Li X; Tai HH
    Curr Cancer Drug Targets; 2012 Jul; 12(6):703-15. PubMed ID: 22515524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells.
    Desai B; Rogers MJ; Chellaiah MA
    Mol Cancer; 2007 Mar; 6():18. PubMed ID: 17343740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The p38 SAPK pathway regulates the expression of the MMP-9 collagenase via AP-1-dependent promoter activation.
    Simon C; Simon M; Vucelic G; Hicks MJ; Plinkert PK; Koitschev A; Zenner HP
    Exp Cell Res; 2001 Dec; 271(2):344-55. PubMed ID: 11716547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERK1/2 mediates TNF-alpha-induced matrix metalloproteinase-9 expression in human vascular smooth muscle cells via the regulation of NF-kappaB and AP-1: Involvement of the ras dependent pathway.
    Moon SK; Cha BY; Kim CH
    J Cell Physiol; 2004 Mar; 198(3):417-27. PubMed ID: 14755547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition and mechanism of action of a protease inhibitor in human pancreatic cancer cells.
    Uchima Y; Sawada T; Nishihara T; Maeda K; Ohira M; Hirakawa K
    Pancreas; 2004 Aug; 29(2):123-31. PubMed ID: 15257104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.